We are live on !
Find out more
Dmitry Balyasny Balyasny Asset Management
AUM
$80.2B
Turnover
42.78%
1-Year Est. Return
51.53%
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
(+4%)
Cap. Flow
-$3.01B
Cap. Flow % of AUM
Cap. Flow %
-3.76%
Top 10 Holdings %
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734
Avg Time Held
Equity + Options
1.1
years
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.95% |
| 2 | Technology | 12.69% |
| 3 | Industrials | 10% |
| 4 | Consumer Discretionary | 7.97% |
| 5 | Healthcare | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2601
Navigator Holdings
NVGS
$1.24B
| $318K | ﹤0.01% |
+17,077
| New | +$370K |
2026 Q2
0 quarters
|
|
2602
Metropolitan Bank Holding Corp
MCB
$1.2B
| $317K | ﹤0.01% |
3,205
-296
| -8% | -$26.8K |
2026 Q1
1 quarter
|
|
2603
Tanger
SKT
$4.51B
| $316K | ﹤0.01% |
+8,000
| New | +$296K |
2026 Q2
0 quarters
|
|
2604
Calumet Specialty Products
CLMT
$3.29B
| $315K | ﹤0.01% |
8,758
+1,540
| +21% | +$51.8K |
2026 Q1
1 quarter
|
|
2605
Brown-Forman Class B
BF.B
$14B
| $315K | ﹤0.01% |
+11,805
| New | +$318K |
2026 Q2
0 quarters
|
|
2606
PUT
Crocs
CROX
$7.38B
| $314K | ﹤0.01% |
2,600
-1,800
| -41% | -$197K |
2023 Q1
13 quarters
|
|
2607
Marcus Corp
MCS
$835M
| $314K | ﹤0.01% |
13,368
-338
| -2% | -$6.65K |
2025 Q4
2 quarters
|
|
2608
Orion Group Holdings
ORN
$316M
| $313K | ﹤0.01% |
18,583
-21,243
| -53% | -$294K |
2025 Q4
2 quarters
|
|
2609
Scansource
SCSC
$893M
| $312K | ﹤0.01% |
+5,985
| New | +$262K |
2026 Q2
0 quarters
|
|
2610
Gen Digital
GEN
$17.8B
| $311K | ﹤0.01% |
12,503
-5,100
| -29% | -$114K |
2025 Q4
2 quarters
|
|
2611
Freedom Holding
FRHC
$11B
| $311K | ﹤0.01% |
2,385
-1,205
| -34% | -$175K |
2026 Q1
1 quarter
|
|
2612
Schwab US Large- Cap ETF
SCHX
$73.1B
| $307K | ﹤0.01% |
+10,429
| New | +$298K |
2026 Q2
0 quarters
|
|
2613
Climb Global Solutions
CLMB
$779M
| $307K | ﹤0.01% |
+13,209
| New | +$283K |
2026 Q2
0 quarters
|
|
2614
CALL
Cameco
CCJ
$32.6B
| $306K | ﹤0.01% |
3,000
-62,000
| -95% | -$6.95M |
2024 Q1
9 quarters
|
|
2615
CALL
Agilent Technologies
A
$50.4B
| $306K | ﹤0.01% |
+2,300
| New | +$280K |
2026 Q2
0 quarters
|
|
2616
PUT
Invesco S&P 500 Equal Weight ETF
RSP
$103B
| $298K | ﹤0.01% |
1,400
-37,600
| -96% | -$7.69M |
2025 Q4
2 quarters
|
|
2617
Nicolet Bankshares
NIC
$3.67B
| $298K | ﹤0.01% |
1,799
+233
| +15% | +$34.4K |
2025 Q3
3 quarters
|
|
2618
CALL
Marriott International
MAR
$108B
| $296K | ﹤0.01% |
800
-300
| -27% | -$111K |
2024 Q4
6 quarters
|
|
2619
Safety Insurance
SAFT
$1.53B
| $296K | ﹤0.01% |
+3,953
| New | +$288K |
2026 Q2
0 quarters
|
|
2620
Milestone Pharmaceuticals
MIST
$96.9M
| $295K | ﹤0.01% |
220,498
-630,827
| -74% | -$1.01M |
2026 Q1
1 quarter
|
|
2621
Preformed Line Products
PLPC
$1.39B
| $295K | ﹤0.01% |
+718
| New | +$252K |
2026 Q2
0 quarters
|
|
2622
Aptiv
APTV
$8.18B
| $295K | ﹤0.01% |
4,801
-687,336
| -99% | -$42M |
2024 Q3
7 quarters
|
|
2623
CALL
Ciena
CIEN
$38.3B
| $294K | ﹤0.01% |
+600
| New | +$306K |
2026 Q2
0 quarters
|
|
2624
McCormick & Company Non-Voting
MKC
$13B
| $291K | ﹤0.01% |
5,762
-1,570,220
| -100% | -$77M |
2024 Q2
8 quarters
|
|
2625
Mativ Holdings
MATV
$662M
| $291K | ﹤0.01% |
+38,377
| New | +$331K |
2026 Q2
0 quarters
|
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.